13K(top 3%)
articles
690.6K(top 2%)
citations
5,005(top 2%)
★★ articles
210(top 2%)
★★★ articles
3(top 13%)
Avg IF
315(top 1%)
H-Index
547(top 1%)
G-Index
1,492
journals

Most Cited Articles of Institut Gustave Roussy in 2014

TitleJournalYearCitations
Self-consumption: the interplay of autophagy and apoptosisNature Reviews Molecular Cell Biology20141.4K
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trialLancet Oncology, The2014982
Effects of long-term exposure to air pollution on natural-cause mortality: an analysis of 22 European cohorts within the multicentre ESCAPE projectLancet, The2014838
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label studyLancet Oncology, The2014753
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanomaNature2014550
Integrated genomic characterization of adrenocortical carcinomaNature Genetics2014423
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasNature Genetics2014413
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialLancet Oncology, The2014359
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancerJournal of Clinical Oncology2014322
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES StudyJournal of Clinical Oncology2014314
A dual role for autophagy in a murine model of lung cancerNature Communications2014296
NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodiesMolecular Biology of the Cell2014292
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinomaJournal of Clinical Oncology2014290
Molecular mechanisms of ATP secretion during immunogenic cell deathCell Death and Differentiation2014283
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trialLancet Oncology, The2014283
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)Lancet Oncology, The2014282
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyAnnals of Oncology2014267
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2014264
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trialLancet Oncology, The2014229
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancerNature Genetics2014228
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancerNature Genetics2014226
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trialLancet Oncology, The2014215
Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour sizeEuropean Radiology2014206
Definition and management of radioactive iodine-refractory differentiated thyroid cancerLancet Diabetes and Endocrinology,the2014194
Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme a stimulates autophagy and prolongs lifespanCell Metabolism2014189